A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes

Completed

Conditions studied: Diabetes Mellitus, Type 1

In brief

The main purpose of this study is to determine whether combining meal, glucose, and insulin data in a web-based system will improve management of type 1 diabetes (T1D). No study drug will be given. The study will last about 18 weeks.

Key facts

Study ID

NCT03758430

Run by

Eli Lilly and Company

People needed

28

Starts

2019-02-06

Expected to finish

2020-08-07

Last updated by the study team

2020-08-21

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• T1D by clinical diagnosis for > 3 years
• Insulin pump use > 3 months: must use one of the following pump types: Animas Ping and Vibe, Insulet Omnipod, Medtronic 523/723 and 530G, Tandem t:slim and t:flex
• Continuous Glucose Monitor (CGM) > 3 months and current use of Dexcom G5 at least 6 out of 7 days per week
• HbA1c 7.0-9.5%
• Must have iPhone (meal-tagging app has been built on iOS)
• Personal computer for uploading of pump and CGM devices
• Willingness to follow study protocol including tagging food data
• Comfort speaking, reading, and writing English

You may not qualify if…

• Individuals currently using a hybrid closed-loop system (e.g., Medtronic 670G)
• Individuals planning to follow a specific diet plan for weight loss
• Inability to consume "common meals"
• Gastroparesis;
• Eating disorder
• Evidence of missed insulin meal-time insulin boluses on pump download
• Use of medications that can affect blood glucose levels (such as SGLT inhibitors, steroid, beta agonists)
• Use of medications that affect gastric emptying (such as GLP agonists, pramlinitide)
• Alcohol abuse
• Pre-conception, pregnancy, or lactation

Where it is running

• Joslin Diabetes Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.